Press Release: PsiloThera, Inc. a Leader in Psychedelic Healthcare Innovation Announces the Filing of U. S. Patents Protecting Its Proprietary Psychedelic Therapeutic Process, Tele-Mental Healthcare & Microdosing Online Platform

CANNANNEW REPORT

HENDERSON, Nev., Sept. 9, 2021 /PRNewswire/ — PsiloThera, Inc. is a pioneering Psychedelic Healthcare Innovation & Life Sciences Company in early stage  development of Psilocybin (“Magic Mushroom”) based drugs and therapies proudly announces the Filing of U. S. Patents Protecting Its Proprietary Psychedelic Therapeutic Process and Tele-Mental Health & Microdosing Platform. PsiloThera’s clinical focus is the development of treatments for Mental Illnesses, Cognitive Diseases & Neurological Disorders. PsiloThera, Inc. a Leader in Psychedelic Healthcare Innovation Announces the Filing of U. S. Patents Protecting Its Proprietary Psychedelic Therapeutic Process, Tele-Mental Healthcare & Microdosing Online Platform PsiloThers’s Tele-Mental Healthcare & Microdosing Platform will provide specialized programs which significantly increase the access to focused-evaluation and life-changing therapy for Veterans, 1st Responders and Patients with treatment resistant mental illnesses. PsiloThera CEO, John Atanasio states, “PsiloThera’s  first U.S. Patent filing is just the beginning of our intellectual property portfolio strategy to protect  PsiloThera’s scientific and medical discoveries, technology breakthroughs & proprietary therapeutic processes.” The U.S. Department of Veterans Affairs (VA) announced  in June 2020 that  Tele-Health “VA Video Connect”  appointments increased by 1,000% between February and May of 2020. The Pandemic has clearly accelerated the consumer adoption curve of Tele-Health. PsiloThera, Director of Research, “Chaplin Chuck” Atanasio, Retired Army Major, Chaplin, Behavioral Scientist and Iraq War Veteran stated, “For over 20 years, I have  dealt with Military mental health and spiritual issues in a wide array of clinical  and non-clinical settings.” “The breakthrough research surrounding Psilocybin creates a major game changer for many Veterans  suffering from  Chronic Depression, Anxiety, PTSD as well as long-term Suicide risk.”  “It is both life-saving and life-changing.” According to “Chaplin Chuck,” For my entire Military career I  have been involved as a 1st Responder and Trainer in Suicide Intervention and Prevention.” “On an annual basis, I trained  hundreds of Military personal in Suicide  Prevention and now more than ever, Veteran Suicide is…

Excerpt only …
READ MORE BELOW
Source : Press Release: PsiloThera, Inc. a Leader in Psychedelic Healthcare Innovation Announces the Filing of U. S. Patents Protecting Its Proprietary Psychedelic Therapeutic Process, Tele-Mental Healthcare & Microdosing Online Platform

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.